ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,667.20
0.64%
Dow Jones
40,954.48
1.85%
US Dollar vs MXN
17.65112
-0.45%
Brent Oil
83.25
-1.29%
Bitcoin
65,131.52
0.43%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) Noticias

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CLSD
FechaHoraFuenteTítuloSímboloCompañía
19/09/202306:05GlobeNewswire Inc.Clearside Biomedical to Participate in Panel Discussion at the Cantor Global Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
13/09/202317:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
14/08/202315:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
14/08/202315:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
14/08/202315:05GlobeNewswire Inc.Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
02/08/202315:30GlobeNewswire Inc.Clearside Biomedical to Participate in Upcoming Investor Conferences in August 2023NASDAQ:CLSDClearside Biomedical Inc
01/08/202306:05GlobeNewswire Inc.Clearside Biomedical to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Monday, August 14, 2023NASDAQ:CLSDClearside Biomedical Inc
31/07/202306:05GlobeNewswire Inc.Clearside Biomedical Highlights Excellent Safety Profile of CLS-AX and Potential for Extended Duration of Effect in Data Presentation at the American Society of Retina Specialists 41st Annual Scientific MeetingNASDAQ:CLSDClearside Biomedical Inc
20/07/202306:05GlobeNewswire Inc.Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at Upcoming ASRS and OIS Scientific MeetingsNASDAQ:CLSDClearside Biomedical Inc
17/07/202306:05GlobeNewswire Inc.Clearside Biomedical Announces Enrollment of Multiple Participants in its ODYSSEY Phase 2b Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
11/07/202315:05GlobeNewswire Inc.Clearside Biomedical CEO George Lasezkay to Present at the SHARE™️ Series Investor Event on Monday, July 17, 2023NASDAQ:CLSDClearside Biomedical Inc
10/07/202306:05GlobeNewswire Inc.Clearside Biomedical Asia-Pacific Partner Arctic Vision Announces the Acceptance in Australia of its New Drug Application for Suprachoroidal Use of Arcatus® for the Treatment of Uveitic Macular EdemaNASDAQ:CLSDClearside Biomedical Inc
23/06/202315:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLSDClearside Biomedical Inc
22/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLSDClearside Biomedical Inc
01/06/202306:05GlobeNewswire Inc.Clearside Biomedical Opens Enrollment in ODYSSEY Phase 2b Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
22/05/202305:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLSDClearside Biomedical Inc
12/05/202316:16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CLSDClearside Biomedical Inc
12/05/202315:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLSDClearside Biomedical Inc
11/05/202306:05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
09/05/202315:30GlobeNewswire Inc.Clearside Biomedical to Participate in a Fireside Chat at the JMP Securities Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
02/05/202306:05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023NASDAQ:CLSDClearside Biomedical Inc
28/04/202307:49Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CLSDClearside Biomedical Inc
28/04/202307:37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CLSDClearside Biomedical Inc
27/04/202306:05GlobeNewswire Inc.Clearside Biomedical Presents Compelling Data at The Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
19/04/202306:05GlobeNewswire Inc.Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at The Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
18/04/202306:05GlobeNewswire Inc.Clearside Biomedical Announces Plans for ODYSSEY Phase 2b Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
12/04/202306:05GlobeNewswire Inc.Clearside Biomedical to Participate in a Fireside Chat at the 22nd Annual Needham Virtual Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
05/04/202306:05GlobeNewswire Inc.Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal PhysiciansNASDAQ:CLSDClearside Biomedical Inc
14/03/202308:23Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CLSDClearside Biomedical Inc
09/03/202315:05GlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Su Consulta Reciente

NASDAQ
AMZN
Amazon.com
PM
XAUUSD
Gold vs US Dollar
NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
NYSE
XOM
Exxon Mobil
COIN
SOLUSD
Solana
FX
USDMXN
US Dollar vs MXN
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
NYSE
MRK
Merck
USOTC
DTEGY
Deutsche Telekom (QX)
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados